Healthcare Investment Access (HIA) Program:
25.11.2025 - 26.03.2026
Seminar
HIA is a high-impact program designed to elevate Nordic healthcare companies onto the global stage, with a strong emphasis on unlocking opportunities in the U.S. capital markets.
Programme elements
Participation rates
Healthcare Investment Access (HIA) Program
Registration deadline: 30 October 2025- $1,500.00 *Participation feeThe participation fee will only be charged to companies selected for the program.$1,500.00 *
* Prices exclude VAT
Sharpen your pitch, elevate your presence and step into the spotlight.
HIA is a high-impact program designed to elevate Nordic healthcare companies onto the global stage, with a strong emphasis on unlocking opportunities in the U.S. capital markets.
Program Highlights:
- Connect directly with leading international investors, venture funds, and strategic partners.
- Gain expert guidance on how to position your company for global capital engagement, with tailored insights into investor expectations outside the Nordic region.
- Initial 360° Review & Mentoring — Comprehensive, multi-disciplinary evaluations covering clinical, commercial, regulatory, and financing dimensions. These reviews identify blind spots, align strategic priorities, and sharpen investor readiness. Followed by two hours of mentoring with seasoned operators and investors. Focused on narrative development, milestone planning, and market-entry strategies to elevate professionalism and execution.
- Learn how to craft compelling pitches and sharpen your messaging for U.S. and European audiences.
- Maximize visibility through curated investor interactions and spotlight appearances at premier events: including the DNB Carnegie Nordic Healthcare Conference in Oslo, a strategically curated European Healthcare Investor Forum in Zurich and the Nordic-American Healthcare Conference in NY.
- Selected companies will be eligible for a stipend to help assist with travel and external advisory needs.
Who Should Apply:
- Nordic healthcare companies led by a CEO or senior executive.
- Teams with at least a Minimum Viable Product (MVP) ready for clinical feedback.
- Companies with no current U.S. market presence, but a clear ambition to scale internationally.
- Ventures with a strong value proposition and readiness to engage global stakeholders.
Program Timeline:
- Oct 30: Application deadline
- Nov 25: Launch and pitch event in Oslo at the DNB Carnegie Nordic Healthcare Conference
- Dec–Mar: Individual investor readiness workshops, training and positioning sessions
- Feb (tbd): European Healthcare Investor Forum in Zurich
- Mar 23–26: Market visit to New York, including pitch events and stakeholder meetings
Apply Now: Don’t miss this chance to accelerate your growth and make a meaningful impact in the U.S. and Global healthcare markets.
Practical information
For more information, please contact our team:
Zacharias Holm
Senior Advisor, Innovation Norway
Andreas Dirnagl
Senior Advisor, Healthcare DNB Bank
Jutta Heix
Head of International Affairs, OCC
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.